Back to results
US 8,299,099 B2Granted
Heteroaryl derivatives as CFTR modulators
AssigneeVertex Pharmaceuticals Incorporated
InventorsSara Hadida Ruah, Mark Miller, Jinglan Zhou, Brian Bear
Life of this patent
Estimating the term…
Abstract
The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Claims3
The compound:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.